Quetiapine use in adults in the community: a population-based study in Alberta, Canada

Ten Years of Antipsychotic Prescribing to Children: A Canadian Population-Based Study

(2017) Silvia Alessi-Severini et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Descriptive Epidemiology of Major Depressive Disorder in Canada in 2012

(2015) Scott B Patten et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?

(2015) T. Pringsheim et al.   BMJ-British Medical Journal

Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?

(2015) T. Pringsheim et al.   BMJ-British Medical Journal

Prescribing of antipsychotics in UK primary care: a cohort study

(2014) Louise Marston et al.   BMJ Open

Diagnoses Associated With Use of Atypical Antipsychotics in a Commercial Health Plan: A Claims Database Analysis

(2013) Leslie Citrome et al.   CLINICAL THERAPEUTICS

Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010

(2012) Stephen Ilyas et al.   BRITISH JOURNAL OF PSYCHIATRY

Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children

(2011) Tamara Pringsheim et al.   DRUG SAFETY

The Pharmacoepidemiology of Antipsychotic Medications for Canadian Children and Adolescents: 2005–2009

(2011) Tamara Pringsheim et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

FDA Panel Issues Mixed Decision on Quetiapine in Depression and Anxiety

(2009) Bridget M. Kuehn   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION